Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Resolor“
Suchtreffer
Begriffe & Kennungen
Resolor
Eintrag öffnenResolor · 4.1 Therapeutic indications · 1
Eintrag öffnenResolor · 4.1 Therapeutic indications · 2
Eintrag öffnenResolor · 4.3 Contraindications · 1
Eintrag öffnenResolor · 4.3 Contraindications · 2
Eintrag öffnenResolor · 4.3 · - Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. - Renal impairme
Eintrag öffnenResolor · 4.3 · - Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. - Renal impairme
Eintrag öffnenResolor · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenResolor · 4.4 Special warnings and precautions for use · 2
Eintrag öffnenResolor · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenResolor · 4.5 Interaction with other medicinal products and other forms of interaction · 2
Eintrag öffnenResolor · 4.5 · 12 Therapeutic doses of probenecid, cimetidine, erythromycin and paroxetine did not affect the pharmacokinetic
Eintrag öffnenResolor · 4.5 · 3 Interactions of similar magnitude may be expected with other potent inhibitors of P-gp such as verapamil, cy
Eintrag öffnenResolor · 4.5 · Although prucalopride may be a weak substrate for P-glycoprotein (P-gp), it is not an inhibitor of P-gp at cli
Eintrag öffnenResolor · 4.5 · Although prucalopride may be a weak substrate for P-glycoprotein (P-gp), it is not an inhibitor of P-gp at cli
Eintrag öffnenResolor · 4.5 · Effects of other medicinal products on pharmacokinetics of prucalopride Ketoconazole (200 mg twice daily), a p
Eintrag öffnenResolor · 4.5 · Effects of other medicinal products on pharmacokinetics of prucalopride Ketoconazole (200 mg twice daily), a p
Eintrag öffnenResolor · 4.5 · Effects of prucalopride on pharmacokinetics of other medicinal products A 30% increase in plasma concentration
Eintrag öffnenResolor · 4.5 · Effects of prucalopride on pharmacokinetics of other medicinal products A 30% increase in plasma concentration
Eintrag öffnenResolor · 4.5 · Prucalopride did not inhibit specific CYP450 activities in in vitro studies in human liver microsomes at thera
Eintrag öffnen